Omics-guided engineering of CHO cells reveals host targets to support AAV production
Konstantina Tzimou, Guillem López-García, Meryem Irem Sipahi, Lars K. Nielsen, Jesús Lavado-García · 2026
Read Omics-guided engineering of CHO cells reveals host targets to support AAV production by Konstantina Tzimou, Guillem López-García, Meryem Irem Sipahi, Lars K. Nielsen, Jesús Lavado-García (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13315805.txt.
Description
Konstantina Tzimou and colleagues investigate, in a 2026 study, why Chinese hamster ovary cells struggle to produce AAV vectors for gene therapy. Scalable vector production remains a manufacturing bottleneck. HEK293 and insect cell systems dominate but carry cost, scalability, and quality limits, while ovary cells, established in drug manufacturing, assemble vectors poorly. The team expressed individual AAV and adenoviral helper proteins in ovary cells and characterized responses with integrated gene and protein analyses.
Energy building was broadly suppressed across conditions, alongside a drop in antiviral nuclear regulation and signaling networks including JAK-STAT and immune gene pathways. Testing host proteins from the analyses, extra copies of nuclear components Mx2 and Rad23A supported vector production, reaching a yield of 10 to the power of 5 vector genomes per milliliter. The authors map ovary cell responses to helper elements and flag both the promise and remaining barriers to a viable ovary-cell platform.
Catalog record
| CREATOR | Konstantina Tzimou, Guillem López-García, Meryem Irem Sipahi, Lars K. Nielsen, Jesús Lavado-García |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 82 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |